FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  	OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5	
                      	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	                      	

1. Name and Address of Reporting Person *

Stueland Katherine	2. Issuer Name and Ticker or Trading Symbol

Invitae Corp [ NVTA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Commercial Officer	
(Last)         (First)         (Middle)

C/O INVITAE CORPORATION, 1400 16TH STREET	3. Date of Earliest Transaction (MM/DD/YYYY)

11/14/2019		
(Street)

SAN FRANCISCO, CA 94103
(City)       (State)       (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)

 	6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person	

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned	
1.Title of Security
(Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code
(Instr. 8)	4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)	
			Code	V	Amount	(A) or (D)	Price				
Common Stock (1)	11/14/2019 	 	S	  	3788 	D	$17.4559 (2)(3)	136053 (4)	D 	 	

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)	
1. Title of Derivate Security
(Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code
(Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	6. Date Exercisable and Expiration Date	7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)	8. Price of Derivative Security
(Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)	
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares					

Explanation of Responses:	
(1) 	These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 14, 2018.	
(2) 	Represents weighted average sale price. Actual sale prices ranged from $17.26 to $17.65.	
(3) 	Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.	
(4) 	Includes an aggregate of 111,017 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.	

Remarks:
Exhibit List
Exhibit 24 - Power of Attorney	

Reporting Owners	
Reporting Owner Name / Address	Relationships	
	Director	10% Owner	Officer	Other	
Stueland Katherine
C/O INVITAE CORPORATION
1400 16TH STREET
SAN FRANCISCO, CA 94103			Chief Commercial Officer		

Signatures		
/s/ Katherine Stueland		11/15/2019	
**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).	
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.	

                                                                      Exhibit 24

                               POWER OF ATTORNEY

        For Executing Section 16 Forms, Form 144 and Schedule 13D or 13G

    Know all by these presents that the undersigned hereby constitutes and
appoints Thomas Brida, Shelly D. Guyer, Robin Tagatac and Robert Werner, or any
of them signing individually, the undersigned's true and lawful attorney-in-fact
to:

(1) prepare, execute in the undersigned's name and on the undersigned's behalf,
    and submit to the Securities and Exchange Commission (the "SEC") a Form ID,
    including amendments thereto, and any other documents necessary or
    appropriate to obtain codes and passwords enabling the undersigned to make
    electronic filings with the SEC of reports required by Section 16(a) of the
    Securities and Exchange Act of 1934 or any rule or regulation of the SEC;
    and

(2) execute for and on behalf of the undersigned, in the undersigned's capacity
    as an officer and/or director of Invitae Corporation (the "Company") (a)
    Forms 3, 4 and 5 (including amendments thereto) in accordance with Section
    16(a) of the Securities Exchange Act of 1934 and the rules thereunder, (b)
    Form 144, and (c) Schedule 13D or Schedule 13G; and

(3) do and perform any and all acts for and on behalf of the undersigned that
    may be necessary or desirable to complete and execute any such Forms 3, 4
    and 5, Form 144, and Schedule 13D or Schedule 13G (including amendments
    thereto) and timely file such Forms or Schedules with the SEC and any stock
    exchange, self-regulatory association or any other authority; and

(4) take any other action of any type whatsoever in connection with the
    foregoing that, in the opinion of such attorney-in-fact, may be of benefit
    to, in the best interest of, or legally required of the undersigned, it
    being understood that the documents executed by the attorney-in-fact on
    behalf of the undersigned pursuant to this Power of Attorney shall be in
    such form and shall contain such terms and conditions as the attorney-in-
    fact may approve in the attorney-in-fact's discretion.

    The undersigned hereby grants to the attorney-in-fact full power and
authority to do and perform all and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that the attorney-in-fact shall lawfully do
or cause to be done by virtue of this Power of Attorney and the rights and
powers herein granted.  The undersigned acknowledges that the foregoing
attorney-in-fact, in serving in such capacity at the request of the undersigned,
is not assuming any of the undersigned's responsibilities to comply with Section
16 of the Securities Exchange Act of 1934.

       The undersigned agrees that such attorney-in-fact may rely entirely on
information furnished orally or in writing by the undersigned to the attorney-
in-fact.  The undersigned also agrees to indemnify and hold harmless such
attorney-in-fact against any losses, claims, damages or liabilities (or actions
in these respects) that arise out of or are based upon any untrue statements or
omissions of necessary facts in the information provided by the undersigned to
such attorney-in fact for purposes of executing, acknowledging, delivering or
filing Form 4 or Form 144 (including amendments thereto) and agrees to reimburse
the attorney-in-fact on demand for any legal or other expenses reasonably
incurred in connection with investigating or defending against any such loss,
claim, damage, liability or action.

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorney-in-fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of the date written below.

Signature:      /s/ Katherine Stueland
                -------------------------------
Printed Name:   Katherine Stueland
                -------------------------------
Date:           November 13, 2019
                -------------------------------